This study represents the general neuroprotective mechanisms of GLP-1RAS, which involve activating the PI3K/Akt pathway, so it modulates PD disruption by enhancing synapse formation and autophagy while inhibiting the accumulation of alpha-synuclein [45]. Here, AKT1 is linked to Parkinson disease.